Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada

Clicks: 302
ID: 273987
2017
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This study demonstrates that strong adherence and SVR with DAAs is achievable, with appropriate supports, even in the context of substance use, and complex health/social issues.
Reference Key
k2017theunderstanding Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mason K;Dodd Z;Guyton M;Tookey P;Lettner B;Matelski J;Sockalingam S;Altenberg J;Powis J;;
Journal The International journal on drug policy
Year 2017
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/28619394
Keywords
hepatitis c canada National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male middle aged Prospective Studies drug therapy combination antiviral agents / therapeutic use* primary health care chronic / drug therapy* sustained virologic response Opiate Substitution Treatment pmid:28619394 doi:10.1016/j.drugpo.2017.05.025 kate mason zoë dodd jeff powis community health services* drug users / psychology* chronic / psychology* medication adherence* vulnerable populations / psychology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.